Home › Funds › Geode Capital Management › EXEL
Geode Capital Management position in EXEL
EXELIXIS INC · Health Care
Latest position (Q2 2026)7.65M sh
Reported value held$416.32M
Portfolio Weight0.02%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 4.01M | $84.71M | New |
| Q4 2021 | 4.12M | $75.25M | Add |
| Q1 2022 | 4.27M | $96.88M | Add |
| Q2 2022 | 4.26M | $88.75M | Hold |
| Q3 2022 | 4.34M | $68.01M | Add |
| Q4 2022 | 4.57M | $73.24K | Add |
| Q1 2023 | 4.77M | $92.55M | Add |
| Q2 2023 | 5.03M | $96.19M | Add |
| Q3 2023 | 5.07M | $110.90M | Add |
| Q4 2023 | 5.15M | $123.46M | Add |
| Q1 2024 | 5.24M | $124.41M | Add |
| Q2 2024 | 5.17M | $116.11M | Reduce |
| Q3 2024 | 5.16M | $134.01M | Hold |
| Q4 2024 | 5.16M | $171.81M | Hold |
| Q1 2025 | 7.42M | $273.90M | Add |
| Q2 2025 | 7.45M | $328.20M | Hold |
| Q3 2025 | 7.67M | $316.85M | Add |
| Q4 2025 | 7.53M | $330.05M | Reduce |
| Q1 2026 | 7.80M | $334.40M | Add |
| Q2 2026 | 7.65M | $416.32M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding EXEL
- BlackRock Inc 29.08M sh · $1.58B · Q2 2026
- Vanguard Group 25.49M sh · $1.12B · Q4 2025
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- Renaissance Technologies 13.43M sh · $730.62M · Q2 2026
- AQR Capital Management 11.02M sh · $598.60M · Q2 2026
- D. E. Shaw & Co 5.55M sh · $302.07M · Q2 2026
- Morgan Stanley 4.52M sh · $245.92M · Q2 2026
- Invesco Ltd 4.50M sh · $244.61M · Q2 2026
- Arrowstreet Capital 4.37M sh · $237.55M · Q2 2026
- Two Sigma Investments 4.21M sh · $229.06M · Q2 2026
- UBS Group AG 3.17M sh · $172.36M · Q2 2026